Preparation and Evaluation of Self-nanoemulsifying Tablets of Carvedilol

Overview

Journal AAPS PharmSciTech

Publisher Springer

Specialty Pharmacology

Date 2009 Feb 25

PMID 19238556

Citations 21

Authors

Enas A Mahmoud

Ehab R Bendas

Magdy I Mohamed

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to combine the advantages of self-nanoemulsifying drug delivery systems and tablets as a conventional dosage form emphasizing the excipients' effect on the development of a new dosage form. Systems composed of HCO-40, Transcutol HP, and medium-chain triglyceride were prepared. Essential properties of the prepared systems regarding carvedilol solubility, a model drug, and self-emulsification time were determined. In order to optimize self-nanoemulsifying drug delivery systems (SNEDDS), formulation dispersion-drug precipitation test was performed in the absence and presence of cellulosic polymers. Furthermore, SNEDDS was loaded onto liquisolid powders. P-glycoprotein (P-gp) activity of the selected SNEDDS was tested using HCT-116 cells. Carvedilol showed acceptable solubility in the selected excipients. It also demonstrated improvement in the stability upon dilution with aqueous media in the presence of cellulosic polymers. Use of granulated silicon dioxide improved the physical properties of liquisolid powders containing SNEDDS. It improved the compressibility of the selected powders and the tested SNEDDS showed marked P-gp inhibition activity. Prepared self-nanoemulsifying tablet produced acceptable properties of immediate-release dosage forms and expected to increase the bioavailability of carvedilol.

Citing Articles

Optimization and Comprehensive Characterization of the Microencapsulation Process for Taro Essence.

Song Y, Gu Y, Ren A, Li X, Wu S, Gong Y Foods. 2025; 14(5).

PMID: 40077456 PMC: 11899469. DOI: 10.3390/foods14050754.

Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats.

Ahmed T, Alotaibi H, Almehmady A, Safo M, El-Say K Nanomaterials (Basel). 2022; 12(22).

PMID: 36432252 PMC: 9695338. DOI: 10.3390/nano12223966.

Enhanced Antioxidant and Anti-Inflammatory Effects of Self-Nano and Microemulsifying Drug Delivery Systems Containing Curcumin.

Jozsa L, Vasvari G, Sinka D, Nemes D, Ujhelyi Z, Vecsernyes M Molecules. 2022; 27(19).

PMID: 36235189 PMC: 9572020. DOI: 10.3390/molecules27196652.

Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing.

Ali H, Ahmed S, Alqurshi A, Alalawi A, Shehata A, Alahmadi Y Pharmaceutics. 2022; 14(9).

PMID: 36145675 PMC: 9504296. DOI: 10.3390/pharmaceutics14091927.

Combined Ramipril and Black Seed Oil Dosage Forms Using Bioactive Self-Nanoemulsifying Drug Delivery Systems (BIO-SNEDDSs).

Shahba A, Sherif A, Elzayat E, Kazi M Pharmaceuticals (Basel). 2022; 15(9).

PMID: 36145341 PMC: 9503356. DOI: 10.3390/ph15091120.

References

Wei L, Sun P, Nie S, Pan W . Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm. 2005; 31(8):785-94. DOI: 10.1080/03639040500216428. View

Kostewicz E, Wunderlich M, Brauns U, Becker R, Bock T, Dressman J . Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. J Pharm Pharmacol. 2004; 56(1):43-51. DOI: 10.1211/0022357022511. View

Gursoy R, Benita S . Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004; 58(3):173-82. DOI: 10.1016/j.biopha.2004.02.001. View

Gershanik T, Haltner E, Lehr C, Benita S . Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity. Int J Pharm. 2001; 211(1-2):29-36. DOI: 10.1016/s0378-5173(00)00591-3. View

Nolte K, Backfisch G, Neidlein R . In vitro absorption studies with carvedilol using a new model with porcine intestine called BM-RIMO (Boehringer-Mannheim ring model). Arzneimittelforschung. 1999; 49(9):745-9. DOI: 10.1055/s-0031-1300495. View

Tuleu C, Newton M, Rose J, Euler D, Saklatvala R, Clarke A . Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004; 93(6):1495-502. DOI: 10.1002/jps.20068. View

Giessmann T, Modess C, Hecker U, Zschiesche M, Dazert P, Kunert-Keil C . CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin Pharmacol Ther. 2004; 75(3):213-22. DOI: 10.1016/j.clpt.2003.10.004. View

Yang S, Gursoy R, LAmbert G, Benita S . Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res. 2004; 21(2):261-70. DOI: 10.1023/b:pham.0000016238.44452.f1. View

Itoh K, Tozuka Y, Oguchi T, Yamamoto K . Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system. Int J Pharm. 2002; 238(1-2):153-60. DOI: 10.1016/s0378-5173(02)00085-6. View

10.

Li P, Ghosh A, Wagner R, Krill S, Joshi Y, Serajuddin A . Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm. 2004; 288(1):27-34. DOI: 10.1016/j.ijpharm.2004.08.024. View

11.

Gao P, Guyton M, Huang T, Bauer J, Stefanski K, Lu Q . Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations. Drug Dev Ind Pharm. 2004; 30(2):221-9. DOI: 10.1081/ddc-120028718. View

12.

Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul A, Khan M . Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002; 240(1-2):103-14. DOI: 10.1016/s0378-5173(02)00130-8. View

13.

Gao P, Rush B, Pfund W, Huang T, Bauer J, Morozowich W . Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003; 92(12):2386-98. DOI: 10.1002/jps.10511. View

14.

Wang S, Monagle J, McNulty C, Putnam D, Chen H . Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process. J Pharm Sci. 2004; 93(11):2755-67. DOI: 10.1002/jps.20183. View

15.

Smith J, Tarocco G, Merazzi F, Salzmann U . Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?. Curr Med Res Opin. 2006; 22(4):709-20. DOI: 10.1185/030079906X96461. View

16.

Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G . Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm. 2004; 278(1):119-31. DOI: 10.1016/j.ijpharm.2004.03.001. View

17.

Muhrer G, Meier U, Fusaro F, Albano S, Mazzotti M . Use of compressed gas precipitation to enhance the dissolution behavior of a poorly water-soluble drug: generation of drug microparticles and drug-polymer solid dispersions. Int J Pharm. 2005; 308(1-2):69-83. DOI: 10.1016/j.ijpharm.2005.10.026. View

18.

Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier J, Piccerelle P . The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm. 2004; 278(2):423-33. DOI: 10.1016/j.ijpharm.2004.03.023. View

19.

Spireas S, Sadu S, Grover R . In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci. 1998; 87(7):867-72. DOI: 10.1021/js970346g. View

20.

Shen H, Zhong M . Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2006; 58(9):1183-91. DOI: 10.1211/jpp.58.9.0004. View